Tokai Pharmaceuticals Inc., a Cambridge-based biopharmaceutical company focused on developing new treatments for prostate cancer, has appointed Jodie Morrison as its new chief executive officer.
Morrison's appointment follows the recent departure of former president and CEO Martin Williams, who left the company to pursue other opportunities, officials said.
Morrison has spent nearly seven years at Tokai, most recently serving as chief operating officer and vice president of clinical affairs. Prior to joining the company, Morrison was director of clinical operations and medical affairs at Dyax Corp., and she previously held clinical management positions at both Curis Inc. and at Diacrin Inc.
Anda sedang membaca artikel tentang
Tokai Pharmaceuticals names Jodie Morrison as new CEO
Dengan url
http://wartawanlocal.blogspot.com/2013/03/tokai-pharmaceuticals-names-jodie.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Tokai Pharmaceuticals names Jodie Morrison as new CEO
namun jangan lupa untuk meletakkan link
Tokai Pharmaceuticals names Jodie Morrison as new CEO
sebagai sumbernya
0 komentar:
Posting Komentar